Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review

V Verma, CB Simone, MV Mishra - JNCI: Journal of the National …, 2018 - academic.oup.com
Background As costs of cancer care rise, the importance of documenting value in oncology
increases. Proton beam radiotherapy (PBT) has the potential to reduce toxicities in cancer …

Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation

V Verma, JCM Rwigema, RS Malyapa… - Radiotherapy and …, 2017 - Elsevier
Reirradiation (reRT) for locoregional recurrences poses unique challenges and risks; re-
treatment using proton beam radiotherapy (PBT) could prove advantageous. Assessing …

Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline

CB Simone II, JA Bogart, AR Cabrera, ME Daly… - Practical radiation …, 2020 - Elsevier
Purpose Several sentinel phase III randomized trials have recently been published
challenging traditional radiation therapy (RT) practices for small cell lung cancer (SCLC) …

Acute and late toxicities of concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer

V Verma, CB Simone, M Werner-Wasik - Cancers, 2017 - mdpi.com
For patients with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC),
concurrent chemoradiotherapy improves overall survival as compared to sequential …

Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional …

S Wei, H Lin, JI Choi, C Shi, CB Simone II… - Radiotherapy and …, 2022 - Elsevier
Purpose To investigate the dosimetric characteristics between an advanced proton pencil
beam scanning (PBS) Bragg peak FLASH technique and conventional PBS planning …

[HTML][HTML] The use of radiation therapy for the treatment of malignant pleural mesothelioma: expert opinion from the National Cancer Institute Thoracic Malignancy …

DR Gomez, A Rimner, CB Simone II, BCJ Cho… - Journal of thoracic …, 2019 - Elsevier
Introduction Detailed guidelines regarding the use of radiation therapy for malignant pleural
mesothelioma (MPM) are currently lacking because of the rarity of the disease, the wide …

Safety of combined immunotherapy and thoracic radiation therapy: analysis of 3 single-institutional phase I/II trials

V Verma, TR Cushman, U Selek, C Tang… - International Journal of …, 2018 - Elsevier
Purpose The safety of combined immunotherapy and thoracic radiation therapy (iRT) has
been understudied. We evaluated toxicities in patients receiving iRT from 3 single …

Survival by histologic subtype of malignant pleural mesothelioma and the impact of surgical resection on overall survival

V Verma, CA Ahern, CG Berlind, WD Lindsay… - Clinical Lung Cancer, 2018 - Elsevier
Introduction For the 3 histologic subtypes of malignant pleural mesothelioma (MPM)—
epithelioid, sarcomatoid, and biphasic—the magnitude of benefit with surgical management …

[HTML][HTML] American Radium Society appropriate use criteria: radiation therapy for limited-stage SCLC 2020

SG Chun, CB Simone II, A Amini, IJ Chetty… - Journal of Thoracic …, 2021 - Elsevier
Introduction Combined modality therapy with concurrent chemotherapy and radiation has
long been the standard of care for limited-stage SCLC (LS-SCLC). However, there is …

A promising treatment strategy for lung cancer: a combination of radiotherapy and immunotherapy

Y Miyasaka, H Sato, N Okano, N Kubo, H Kawamura… - Cancers, 2021 - mdpi.com
Simple Summary Lung cancer is a leading cause of cancer-related deaths worldwide. In the
past few decades, radiotherapy has achieved outstanding technical advances and is widely …